CLINICAL_TRIALS
trial_result
· 2024-08-01
Clinical Trial Update: Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients [Phase 4]
Summary
Phase 4 maintenance trial in newly diagnosed multiple myeloma evaluating ixazomib, lenalidomide, and the combination.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Multiple Myeloma | Phase 4 | Status: COMPLETED